As of Feb 23
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.13, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +80.15% increase from the last price of 3.40.
The current consensus among 4 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.